CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-07 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −29,050 | $79.86 | $2.3M | 54,251.82 |
| 2023-08-07 | MUSSALLEM MICHAEL A Director | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −29,350 | 264,150 | ||
| 2023-07-31 | Zovighian Bernard J CEO | Other acquisition | +2,558.62 | $83.54 | $214K | 47,111.49 |
| 2023-07-31 | Ullem Scott B. CVP, Chief Financial Officer | Exercise or conversion 10b5-1 | +7,255 | $36.75 | $267K | 26,503 |
| 2023-07-31 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −7,255 | $84.35 | $612K | 19,248 |
| 2023-07-31 | Ullem Scott B. CVP, Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −7,255 | 65,290 | ||
| 2023-07-14 | BOBO DONALD E JR CVP,Strategy/Corp Development | Exercise or conversion 10b5-1 | +3,500 | $36.75 | $129K | 43,002.69 |
| 2023-07-14 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −3,500 | $92.94 | $325K | 39,502.69 |
| 2023-07-14 | BOBO DONALD E JR CVP,Strategy/Corp Development | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −3,500 | 76,000 | ||
| 2023-07-14 | Wood Larry L Global President TAVR & Surg | Exercise or conversion 10b5-1 | +8,660 | $45.28 | $392K | 222,453.71 |
| 2023-07-14 | Wood Larry L Global President TAVR & Surg | Sale 10b5-1 | −8,660 | $92.94 | $805K | 213,793.71 |
| 2023-07-14 | Wood Larry L Global President TAVR & Surg | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −8,660 | 41,059 | ||
| 2023-07-10 | Szyman Catherine M. CVP, Critical Care | Exercise or conversion 10b5-1 | +5,000 | $36.75 | $184K | 39,813.57 |
| 2023-07-10 | Szyman Catherine M. CVP, Critical Care | Sale 10b5-1 | −5,000 | $90.52 | $453K | 34,813.57 |
| 2023-07-10 | Szyman Catherine M. CVP, Critical Care | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −5,000 | 62,000 | ||
| 2023-07-07 | Szyman Catherine M. CVP, Critical Care | Shares withheld for taxes 10b5-1 | −252 | $90.46 | $23K | 34,813.57 |
| 2023-07-07 | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Shares withheld for taxes | −81 | $90.46 | $7K | 173,583.78 |
| 2023-07-05 | MUSSALLEM MICHAEL A Director | Exercise or conversion 10b5-1 | +29,350 | $36.75 | $1.1M | 83,601.82 |
| 2023-07-05 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −7,622 | $91.22 | $695K | 75,979.82 |
| 2023-07-05 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −21,728 | $90.63 | $2.0M | 54,251.82 |
Page 36 of 43 · 841 trades